- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genome And Co (314130)
Genome And Co stock price live, this page displays KQ 314130 stock exchange data. View the 314130 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genome And Co real time stock price chart below.
What Is the Genome And Co Stock Price Today?
The Genome And Co stock price today is 4,230.
What Is the Stock Symbol for Genome And Co?
The stock symbol for Genome And Co is "314130."
What Stock Exchange Does Genome And Co Trade On?
Genome And Co is listed and trades on the KOSDAQ stock exchange.
Is Genome And Co a Good Stock to Buy?
Determining whether Genome And Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 314130 quote. (ISIN: KR7314130006)
What Is the Genome And Co Stock Price Today?
The Genome And Co stock price today is 4,230.
What Is the Stock Symbol for Genome And Co?
The stock symbol for Genome And Co is "314130."
What Stock Exchange Does Genome And Co Trade On?
Genome And Co is listed and trades on the KOSDAQ stock exchange.
Is Genome And Co a Good Stock to Buy?
Determining whether Genome And Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 314130 quote. (ISIN: KR7314130006)
KOSDAQ
Currency in KRW
4,230
-390(-8.44%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,145
4,625
52 wk Range
2,440
10,180
314130 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,1454,625
52 wk Range
2,44010,180
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
314130 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Earnings
Latest Release
May 15, 2026
EPS / Forecast
-182.17 / --
Revenue / Forecast
5.78B / --
Compare 314130 to Peers and Sector
Metrics to compare | 314130 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship314130PeersSector | |
|---|---|---|---|---|
P/E Ratio | −40.2x | −8.5x | −0.3x | |
PEG Ratio | −0.52 | −0.14 | 0.00 | |
Price/Book | 2.3x | 1.9x | 2.6x | |
Price / LTM Sales | 9.6x | 3.5x | 3.1x | |
Upside (Analyst Target) | - | 36.8% | 49.0% | |
Fair Value Upside | Unlock | 15.6% | 6.3% | Unlock |
Genome & Company, a clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea, Asia, Europe, South America, North America, and internationally. Its lead product candidate is GEN-001, an oral microbiome therapeutic candidate developed to have immune modulating activities. The company also develops GEN-501 targeting the non-responders of Dupilumab drugs with atopic skin diseases; and GENA-104 for the treatment of solid tumors, as well as microbiome-based products, including therapeutics, cosmeceuticals, and dietary supplements. In addition, it has a partnership with US Scioto Biosciences for the development of SB-121, which targets disorders related to the gut-brain axis, such as Autism Spectrum Disorder (ASD), as well as disorders related to gut-injury, including Necrotizing Enterocolitis (NEC). The company was founded in 2015 and is headquartered in Suwon-si, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Genome (314130) Stock Price Today?
The Genome stock price today is 4,230 KRW.
What Stock Exchange Does Genome Trade On?
Genome is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Genome?
The stock symbol for Genome is "314130."
What Is the Genome Market Cap?
As of today, Genome market cap is 241.62B KRW.
What Is Genome's Earnings Per Share (TTM)?
The Genome EPS (TTM) is -177.
From a Technical Analysis Perspective, Is 314130 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Genome Stock Split?
Genome has split 1 times.
What is the current trading status of Genome (314130)?
As of Aug 18, 2026, Genome (314130) is trading at a price of 4,230 KRW, with a previous close of 4,620 KRW. The stock has fluctuated within a day range of 4,145 KRW to 4,625 KRW, while its 52-week range spans from 2,440 KRW to 10,180 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.